Serena Williams, one of the most successful athletes of all time, has spoken out about using weight loss drugs - she says, to ...

Sara H. Jodka of Dickinson Wright PLLC discusses the legal landscape surrounding GLP-1 programs for weight loss, in light of ...

A new European obesity framework adds waist-to-height ratio and comorbidities to BMI assessment. Could this help identify ...

U.S. prices for obesity-treatment pills that Eli Lilly and Novo Nordisk aim to launch next year likely will be on par with ...

Obesity before pregnancy, not just during, may shape a child’s brain and raise the risk of autism spectrum disorder, a new ...

With results from highly anticipated trials of Eli Lilly’s orforglipron and Viking Therapeutics’ VK2735 “underwhelming” ...

The COVID-19 pandemic drastically altered health care across the globe, with obesity management undergoing significant ...

For patients with inflammatory bowel disease and obesity, bariatric surgery is associated with improved inflammatory bowel ...

This week on "The Readout LOUD," we discuss Viking Therapeutics' obesity flop and dish on the growing "pharm to table" ...

Viking Therapeutics’ VK2735 achieves a 10.9% placebo-adjusted weight loss at 13 weeks, but a less than ideal safety profile ...

Living at higher altitudes in Colombia is linked with lower childhood obesity rates, influenced by metabolism, hormones, and ...

A new study has created the first single-cell map of how DNA is regulated and organized inside different cell-types of human ...